Radiopharm Theranostics Ltd
RADX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001949257
No open-market purchases or sales by Radiopharm Theranostics Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $1.18M in total; no superinvestor holds it.
Other share classesRDPTF
13F holders, Q2 2026
Institutional positions in Radiopharm Theranostics Ltd as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 6
- −1 vs. Q1 2026
- Shares held
- 51.1M
- −184.0K (−0.4%) vs. Q1 2026
- Total value
- $1.18M
- −$880.8K (−42.7%) vs. Q1 2026
- New holders
- 0
- 3 more added
- Sold out
- 1
- 1 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RADX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 6 | $1.18M |
| Q1 2026 | 7 | $2.06M |
| Q4 2025 | 11 | $4.68M |
| Q3 2025 | 4 | $1.73M |
| Q2 2025 | 5 | $1.58M |
| Q1 2025 | 3 | $1.65M |
| Q4 2024 | 4 | $1.94M |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Radiopharm Theranostics Ltd; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 51,000,000 | $670.5K | 0.51% | 00.0% | Unchanged |
| HSBC Holdings PLC | 62,188 | $253.7K | 0.00% | +816+1.3% | Added |
| VGI Partners Ltd | 40,138 | $168.2K | 0.01% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 20,000 | $83.8K | 0.00% | +4,000+25.0% | Added |
| UBS Group AG | 1,507 | $6.31K | 0.00% | −1,493−49.8% | Reduced |
| Rhumbline Advisers | 195 | $817 | 0.00% | +74+61.2% | Added |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −187,406−100.0% | Sold out |